Tag: U.K.
-
Celgene Adopting A.I. Drug Discovery Technology
Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find treatment candidates for cancer and autoimmune disorders.
-
Venture Funds, Mergers in A.I. Up Sharply in 2018
Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows.
-
Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.
-
Spin-Off Producing Commercial-Grade Graphene
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics.
-
Population Data Show Genetics-Health Links
The first batch of data from a large-scale genomic sequencing project in the U.K. shows strong associations between several gene variations and common health conditions.
-
Infographic – Mobile Internet Costs Worldwide
Our friends at Statista provide an indication of the cost paid by consumers for transmitting those data over the mobile internet in many countries of the world.
-
Biogen Acquires Gene Therapy Company in $800M Deal
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen.
-
Trials Underway Testing Crispr for Blood Disorders
Clinical trials testing the genome editing technique Crispr for sickle cell disease and beta thalassemia, two inherited blood disorders, enrolled and infused their first patients.
-
Asthma Drug Shown to Lower Airway Muscle Mass
An experimental drug is shown in a clinical trial and computer modeling to reduce the mass of smooth muscle tissue that builds up in airways of people with asthma.
-
Brain Tissue Model Devised for Cancer Drug Testing
A three-dimensional brain tissue model, including a patient’s tumor cells, shows in lab tests an ability to test current and experimental cancer drugs.